Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomic-Guided Tacrolimus Dosing in Kidney Transplant
NCT03020589Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2017
- Primary completion
- Jul 2021
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by University of North Carolina at Chapel Hill. Started Feb 2017; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT03020589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020589.